Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid following Rituxan and Fludara in untreated CLL
NCT00860457Phase 2Completed
- Sponsor
- Georgetown University
- Start
- Feb 2008
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in chronic lymphocytic leukemia (CLL), sponsored by Georgetown University. Started Feb 2008; status: completed.
02
Drugs
lenalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00860457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00860457.